A Facebook survey conducted before New Zealand’s new medicinal cannabis system came into effect found two-thirds of those using the medicine would get a prescription using the scheme rather than continuing to use the drug illegally.

Funded by the NZ Health Research Council and conducted by Massey University, the survey of 3,634 medicinal cannabis users found 66% were interested in transitioning to the country’s new prescription scheme.

Some 66% of New Zealanders surveyed would prefer to use the country’s new medicinal cannabis scheme

Younger people and those with a higher income were more likely to say they would get a prescription, while those who identified as Maori, lower income groups, and those who grew their own cannabis at home were less likely to say they would.

The researchers surmised this “may highlight a perception that the new scheme is restrictive and expensive”.

Last year, new legislation came into force allowing medical professionals to prescribe cannabis for medicinal purposes.

So far, Tilray is the only company to have products verified as meeting the minimum quality standards under the system.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...